News & Press Releases

Filter
432 found

Report published on ‘Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy’

03 Apr 2008
General

MMV co-sponsor of RBM Partnership’s Zambezi Expedition

28 Mar 2008
General

Position paper and presentations: Exploring combinations of antimalarial drugs meeting

19 Mar 2008
General

Dacart development halted based on Phase III results

29 Feb 2008
R&D

MMV and other PPPs encourage additional US Government support

11 Jan 2008
Donors

MMV features in The Pulse on Al Jazeera

04 Jan 2008
General

MoH - MMV: Bold intervention being designed in Uganda to deliver subsidized effective antimalarials

01 Oct 2007
Access & product management

DHA Piperaquine wins Good Clinical Practice Journal (GCPj) Award

06 Sep 2007
R&D

US NIH grants MMV over USD 5 mn for malaria research

06 Sep 2007
Donors, R&D

Start of Phase II trial of intravenous artesunate for children with severe malaria

29 Aug 2007
R&D

Orphan Drug Status for MMV Drug DHA-Piperaquine

25 Jul 2007
R&D

World Bank Reviews MMV’s Growth and Progress

18 Jul 2007
Donors

MMV Project of the Year goes to Next Generation OZ

14 May 2007
R&D

New malaria clinical trial site inaugurated at Bagamoyo, Tanzania

10 May 2007
R&D

Dr Chris Hentschel interviewed in Kampala by AllAfrica.org

09 May 2007
General

Uganda and MMV explore innovative ways to give patients access to life-saving antimalarials

09 May 2007
Access & product management

Africa Malaria Day - A Malaria Community Statement

25 Apr 2007
General

Partnerships hold the key

25 Apr 2007
General

DNDi launches a fixed-dose ACT

02 Mar 2007
R&D

Work of MMV highlighted at World Economic Forum Annual Meeting

31 Jan 2007
General

Pivotal clinical trials launched for new artemisinin-based malaria drug combination

25 Jan 2007
R&D

Malaria Map: New Tool for Malaria Control

06 Dec 2006
General

Dutch government pledges nearly €7 million to MMV

03 Nov 2006
Donors

Medicines for Malaria Venture, Higher Colleges of Technology and Global Medical Forum Foundation Collaborate on Innovative Abu Dhabi Bio City Research Initiative to Tackle Malaria

18 Oct 2006
General

MMV announces a commitment of US$50 million to advance malaria research at President Clinton’s Global Initiative

21 Sep 2006
General

Pivotal Studies Begin for CDA in sub-Saharan Africa

25 Jul 2006
R&D

Project to jump-start efficacy of Artemisia Annua

22 Jun 2006
R&D

MMV calls for action against counterfeit drugs

06 Jun 2006
General

Novartis spearheads innovative malaria research project in newly created public-private partnership

23 May 2006
R&D

Irish Aid announces a grant to MMV of €9 million over the next three years

11 May 2006
Donors

MMV Stakeholders’ Meeting - Shin Poong Pharm. wins Project of the Year

06 May 2006
General

New Alliance to Build African Capacity for Malaria Drug and Vaccine Research

24 Apr 2006
General

MMV applauds WHO’s call to halt malaria monotherapy

23 Jan 2006
General

University of Mississippi, MMV, and DNDi to collaborate on development of anti-parasitic drugs

14 Dec 2005
R&D

RBx11160 demonstrates significant parasite reduction in patients

13 Dec 2005
R&D

MMV swims 10 km in World Swim for Malaria

03 Dec 2005
General

New ACT confirms potential use against malaria

13 Nov 2005
R&D

Gates Foundation commits $258.3 mn for malaria R&D with $100 mn for MMV

31 Oct 2005
Donors

Landmark study: malaria gets less than 1% of global health R&D investment

30 Oct 2005
General

DfID and the Wellcome Trust announce new grant for MMV

29 Oct 2005
Donors

Dihydroartemisinin and Piperaquine could become a major weapon against malaria

03 Oct 2005
R&D

Pyronaridine-Artesunate (PANDA)

15 Aug 2005
R&D

Open Letter to Leaders of the G-8 Nations

17 Jun 2005
General

GlaxoSmithKline and University of California, San Francisco win Medicines for Malaria Venture’s Project of the Year 2004 Award

29 May 2005
R&D

MMV and GlaxoSmithKline collaborate to fight malaria

11 Nov 2004
R&D

USAID announces $16 million for new malaria initiatives, $8 million for MMV

27 Oct 2004
Donors

Nature publishes research paper, Identification of an antimalarial synthetic trioxolane drug development candidate

19 Aug 2004
R&D

BHP Billiton joins Medicines for Malaria Venture in the fight against malaria

02 Jun 2004
Donors

GlaxoSmithKline wins Medicines for Malaria Venture’s Project of the Year Award 2003

01 Jun 2004
R&D

GlaxoSmithKline, WHO/TDR and the Medicines for Malaria Venture collaborate to fight malaria

23 Apr 2004
R&D

Chongqing Holley, Sigma Tau, Medicines for Malaria Venture and University of Oxford sign historic partnership agreement to develop antimalarial drug

19 Mar 2004
R&D

University of Mississippi and Medicines for Malaria Venture Explore New Drug Compound for Treatment of Malaria

02 Mar 2004
R&D

Paratek Pharmaceuticals and Medicines for Malaria Venture collaborate to discover novel antimalarial compounds

24 Feb 2004
R&D

Dr Pascoal Mocumbi, named High Representative of the European and Developing Countries Clinical Trials Partnership (EDTCP) by the European Commission

19 Jan 2004
General

Medicines for Malaria Venture, Immtech and University of North Carolina at Chapel Hill sign agreement to develop a new treatment for malaria

03 Dec 2003
R&D

Medicines for Malaria Venture and Novartis agree to develop a pediatric formulation of Coartem®

10 Nov 2003
R&D

Dr Pascoal Manuel Mocumbi, Prime Minister of Mozambique, joins MMV Board

13 Oct 2003
General

The Bill & Melinda Gates Foundation commits $168 million to accelerate malaria research

21 Sep 2003
Donors

Pfizer reports important research developments against malaria

26 Jun 2003
R&D

Medicines for Malaria Venture and GlaxoSmithKline (GSK) team up to fight malaria in developing countries

13 Jun 2003
General

Pages